Results 251 to 260 of about 1,013,409 (339)
Cardioprotective effects of semaglutide on isolated human ventricular myocardium
Semaglutide reduces late sodium current (INa) and diastolic calcium (Ca) sparks in human cardiomyocytes from aortic stenosis (AS) and end‐stage heart failure with reduced ejection fraction (HFrEF) patients, thereby increasing Ca transients. Improved Ca storage may underly the enhanced contractility of human cardiomyocytes upon semaglutide.
Thomas Krammer+16 more
wiley +1 more source
Khodadoust Line Indicating Graft Rejection in Descemet's Stripping Automated Endothelial Keratoplasty: A Unique Case Report. [PDF]
Oliver-Gutierrez D+3 more
europepmc +1 more source
EVIDENCE THAT DRUG-RESISTANT ALLOREACTIVE T CELLS MAY CONTRIBUTE TO HUMAN GRAFT REJECTION
William L. Stanford+2 more
openalex +1 more source
Effects of digitoxin compared to placebo on efficacy and safety in patients with heart failure and reduced ejection fraction (HFrEF). Primary endpoint: time to all‐cause death and first hospitalization for worsening heart failure (whatever occurs first). ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin
Udo Bavendiek+35 more
wiley +1 more source
Exploring personalized treatment for cardiac graft rejection based on a four-archetype analysis model and bioinformatics analysis. [PDF]
Shi H+12 more
europepmc +1 more source
Tetrazolium vital staining for early detection of corneal graft rejection
Istiantoro Sukardi+2 more
openalex +2 more sources
Efficacy and Safety of C‐MIC Device in Patients with Heart Failure with Reduced Ejection Fraction. 6MWD, 6‐min walk distance; CI, confidence interval; KCCQ‐OSS, Kansas City Cardiomyopathy Questionnaire overall summary score; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.
Jesus E. Rame+24 more
wiley +1 more source